News

Dimensions Launches ‘ASCEND’ International Plant Medicine Retreat Series in Jamaica

ASCEND Destination Retreat Program Will Combine Legal Plant Medicine Experiences With Immersive Luxury Hospitality at Good Hope Estate In Trelawny,…

2 years ago

Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering

CAMBRIDGE, Mass., June 14, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

2 years ago

Pike Therapeutics Announces Positive Pharmacokinetic Animal Study Results and Unexpected Benefits for its Proprietary Weekly CBD Continuous Transdermal Delivery Technology

HIGHLIGHTS:   - Positive 7-day continuous delivery of CBD in rabbits equivalent to 35 mg/kg/day oral rabbit dose- Positive skin irritation…

2 years ago

Healthy Extracts CEO Discusses Health and Wellness on Here’s To Your Health With Joshua Lane

LAS VEGAS, June 14, 2022 (GLOBE NEWSWIRE) -- Duke Pitts, CEO of Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator…

2 years ago

Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea

Study Recently Presented at the SLEEP 2022 Annual MeetingLITTLETON, Colo., June 14, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS)…

2 years ago

WIMI Hologram Academy:5G Network enhanced XR-D2D based XR content transfer

HONG KONG, June 14, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

Pharvaris Announces Annual Meeting of Shareholders

ZUG, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to…

2 years ago

HEXO Enters Into Amending Agreements to the Transaction Agreement With Tilray Brands and the Standby Agreement With KAOS

MARKET CONDITIONS DICTATE RESETTING OF AGREEMENT TERMS STANDBY AGREEMENT CONDITIONS AMENDED IN HEXO’S FAVOUR HEXO TO FILE SUPPLEMENT TO MANAGEMENT…

2 years ago

Outlook Therapeutics Confirms Status of Biologics License Application (BLA) Submission for ONS-5010

Outlook Therapeutics reiterates expected re-submission of BLA by September 2022 following receipt of additional correspondence from U.S. Food and Drug…

2 years ago

Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility

AD/PD Laboratories Open Exactly Eight Months After Announced Plans to Build Viral Vector Facility Build-Out of Facility’s CGMP Manufacturing Suites…

2 years ago